Skip to main content

Free, publicly available health data proves to be research gold mine

Free, publicly available health data proves to be research gold mine :

Discovery could help determine which cancer patients will benefit from immuno therapy.


It's a popular question: What did you do over the summer? For Lubaba (Aurna) Khan, the summer of 2018 will be one she will never forget.
It started on a high note and ended on an even higher one. In June, Khan walked across the stage to accept her degree as a University of Calgary Bachelor of Health Sciences graduate. She received an O'Brien Centre Summer Studentships award, landing a research job with Dr. Pinaki Bose, PhD. Then, unexpectedly, she made a discovery that could help cancer patients throughout the world.
Khan spent the summer hunched over a computer interpreting free, publicly accessible health and genomics data. "Bioinformatics is the new frontier of medical science," says Khan. "I started my medical education as a biomedical student, looking at cells through a microscope, but looking at cancer biology with the assistance of a computer opens up a new way of thinking about research."
Khan was comparing the differences between genes found in cancer cells and those found in normal cells. Working under the guidance of Bose, Khan learned how to construct questions and hypotheses. It was a bumpy start.
"We wanted to find out how immune genes in cancer cells might be associated with immuno therapy response. There was nothing there, and we were disappointed," says Bose, who is an adjunct assistant professor in the departments of biochemistry and molecular biology, and oncology, and is a member of the Arnie Charbonneau Cancer Institute at the Cumming School of Medicine.
"We adjusted our focus, and discovered that another set of genes, those associated with the extracellular matrix, had a direct connection to how cancer patients respond to immuno therapy."
Immuno therapy has become a popular treatment for some cancers. It uses the body's own immune system to attack and kill cancer cells. The treatment is effective, but only for a select few, around 20 to 30 per cent of patients. There is not a clear understanding as to why some people respond better to immuno therapy than others.
The extracellular matrix may hold some of the answers; it grows within and around both healthy and cancerous cells.
"We found that genes associated with the extracellular matrix are overly produced in patients who do not respond to immuno therapy," says Bose, who is also the director of translational research for the Ohlson Research Initiative. "These genes are produced by cells surrounding the tumour, and they form a barrier which helps cancer cells evade detection by the immune system."
The UCalgary team shared the discovery with researchers at the University of Toronto who have validated the findings, now published in Nature Communications. "I was like, wow, I'm a student. I didn't realize how important this was until Dr. Bose pointed out how significant this discovery could be in cancer treatment. It kind of threw me off, but I was extremely excited at the same time," says Khan, who is a co-first author on the study.
The researchers looked more deeply at their findings and discovered a gene signature, which could lead to the development of a simple test that could help determine which patients would benefit from immuno therapy. The next step will be to prove the findings in a lab.
"Analyzing big data won't replace bench science, but it a great tool for hypothesis-building and leading to new insights," says Bose.
For Khan, this experience has changed the course of her future studies. She always planned to pursue a master's degree in public health, and now sees a future focused on data analysis rather than data collection.
Pinaki Bose's research is supported by Ohlson Research Initiative and the Charbonneau Cancer Institute.

Comments

Post a Comment

Popular posts from this blog

Size matters: New data reveals cell size sparks genome awakening in embryos

Transitions are a hallmark of life. When dormant plants flower in the spring or when a young adult strikes out on their own, there is a shift in control. Similarly, there is a transition during early development when an embryo undergoes biochemical changes, switching from being controlled by maternal molecules to being governed by its own genome. For the first time, a team from the Perelman School of Medicine at the University of Pennsylvania found in an embryo that activation of its genome does not happen all at once, instead it follows a specific pattern controlled primarily by the various sizes of its cells. The researchers published their results this week as the cover story in  Developmental Cell . In an early embryo undergoing cell division, maternally loaded RNA and proteins regulate the cell cycle. The genomes of the zygote -- a term for the fertilized egg -- are initially in sleep mode. However, at a point in the early life of the embryo, these zygotic nuclei "wake...
Post a Comment
Read more

Home births as safe as hospital births: International study suggests

A large international study led by McMaster University shows that low risk pregnant women who intend to give birth at home have no increased chance of the baby's perinatal or neonatal death compared to other low risk women who intend to give birth in a hospital. The results have been published by  The Lancet 's  EClinicalMedicine  journal. "More women in well-resourced countries are choosing birth at home, but concerns have persisted about their safety," said Eileen Hutton, professor emeritus of obstetrics and gynecology at McMaster, founding director of the McMaster Midwifery Research Centre and first author of the paper. "This research clearly demonstrates the risk is no different when the birth is intended to be at home or in hospital." The study examined the safety of place of birth by reporting on the risk of death at the time of birth or within the first four weeks, and found no clinically important or statistically different risk between home...
Post a Comment
Read more

Molecular adlayer produced by dissolving water-insoluble nanographene in water

Molecular adlayer produced by dissolving water-insoluble nanographene in water : "Nanographene incorporated micelle capsules" can be prepared by simply pulverizing and mixing nanographene with amphiphilic V-shaped anthracene molecules in water at room temperature. Even though nanographene is insoluble in water and organic solvents, Kumamoto University (KU) and Tokyo Institute of Technology (Tokyo Tech) researchers have found a way to dissolve it in water. Using "molecular containers" that encapsulate water-insoluble molecules, the researchers developed a formation procedure for a nanographene adlayer, a layer that chemically interacts with the underlying substance, by just mixing the molecular containers and nanographene together in water. The method is expected to be useful for the fabrication and analysis of next-generation functional nanomaterials. Graphene is a single layer of carbon atoms arranged in sheet form. It is lighter than metal wit...
Post a Comment
Read more